Evidence map›Paper›PMID 30088094›Full record

ArticleLung2018

Needs, Perceptions and Education in Sarcoidosis: A Live Interactive Survey of Patients and Partners.

C C Moor, M J G van Manen, P M van Hagen, J R Miedema, L M van den Toorn, Y Gür-Demirel, A P C Berendse, J A M van Laar, M S Wijsenbeek

Abstract read
In one paragraph

Article in Lung, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Review
  4. Quality of Life in Sarcoidosis.Diagnostics (Basel, Switzerland) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Comprehensive Care for Patients with Sarcoidosis.Journal of clinical medicine · 2020
    Review
  18. Predictors of cough-specific and generic quality of life in sarcoidosis patients.Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG · 2020
    Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

C C MoorDepartment of Respiratory Medicine, Erasmus University Medical Center, s-Gravendijkwal 230, Rotterdam, 3015 CE, The Netherlands.
M J G van ManenDepartment of Respiratory Medicine, Erasmus University Medical Center, s-Gravendijkwal 230, Rotterdam, 3015 CE, The Netherlands.
P M van HagenDepartments of Immunology and Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
J R MiedemaDepartment of Respiratory Medicine, Erasmus University Medical Center, s-Gravendijkwal 230, Rotterdam, 3015 CE, The Netherlands.
L M van den ToornDepartment of Respiratory Medicine, Erasmus University Medical Center, s-Gravendijkwal 230, Rotterdam, 3015 CE, The Netherlands.
Y Gür-DemirelDepartment of Respiratory Medicine, Erasmus University Medical Center, s-Gravendijkwal 230, Rotterdam, 3015 CE, The Netherlands.
A P C BerendseDutch Sarcoidosis Patient Organisation (Sarcoidose.nl), Alkmaar, The Netherlands.
J A M van LaarDepartments of Immunology and Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.
M S WijsenbeekDepartment of Respiratory Medicine, Erasmus University Medical Center, s-Gravendijkwal 230, Rotterdam, 3015 CE, The Netherlands. m.wijsenbeek-lourens@erasmusmc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSarcoidosis is a chronic, multisystem disease with often a major impact on quality of life. Information on unmet needs of patients and their partners is lacking. We assessed needs and perceptions of sarcoidosis patients and their partners.

methodsDuring patient information meetings in 2015 and 2017 in the Erasmus University Medical Center, we interviewed patients and partners using interactive voting boxes. Patients responded anonymously to 17 questions. Answers were projected directly on the screen in the room.

results210 patients and 132 partners participated. Sarcoidosis has a subjective significant impact on lives of both patients and partners. The vast majority of patients and partners feel regularly misunderstood because of the general unawareness of sarcoidosis. Many patients and partners experience anxiety. Three-quarters of patients would like to see more attention and support for their psychological problems. Additionally, more supportive care for partners of sarcoidosis patients is warranted. Interactive interviewing was considered educational (91%) and pleasant (84%). DISCUSSION: This study improves awareness of needs and perceptions of patients with sarcoidosis and their partners. Sarcoidosis leads to anxiety and psychological distress and impairs well-being of patients and their partners. Attention for psychological support, better disease education, and more supportive care for partners is warranted.

Indexed as

Attitude to HealthQuality of LifeSocial SupportAnxietyHumansNeeds AssessmentSarcoidosisSpouses

Identifiers

PMID30088094
PMCPMC6153596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.